Nowatch is a health technology company based in Amsterdam led by Hylke Muntinga and Timothée Manschot. Its flagship product, the Nowatch wearable, measures and predicts stress by inferring cortisol levels through ElectroDermal Activity (EDA) biosensing developed in partnership with Philips. The device also tracks sleep, activity, heart rate and temperature, and can alert users to cumulative stress overload up to 60 minutes in advance. The company raised $8.7M in a Series A and intends to use the funds to expand its marketing reach, scale research and development efforts, and grow its internal team. Chris Hall and Flow Ventures led the round, and Hall joins Nowatch as chairman of the board. The financing is intended to support product development and commercial scaling in the awareable health space.

Total raised

$9M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2022